Skip to main content

Smith Salley Wealth Management

Position in GILD — Gilead Sciences, Inc.

CIK 1482012 GREENSBORO, NC

Position in GILD

as of Mar 31, 2026 · filed Apr 16, 2026
Position Value
$206,267
-$611,852 QoQ
Shares Held
1,480
-85.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Smith Salley Wealth Management holds $107,302,312 across 8 Drug Manufacturers - General names.

# Ticker Company Shares Value (USD) Open

All Filings in GILD

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $206,267 1,480
2023-12-31 $818,119 10,099
2023-09-30 $761,090 10,156
2023-06-30 $846,382 10,982
2023-03-31 $1,009,744 12,170
2022-12-31 $1,092,183 12,722
2022-09-30 $778,835 12,625
2022-06-30 $780,350 12,625
2022-03-31 $699,606 11,768
2021-12-31 $4,234,033 58,312
2021-09-30 $4,078,820 58,394
2021-06-30 $4,034,162 58,585
2021-03-31 $3,699,549 57,242
2020-12-31 $2,648,790 45,465
2020-09-30 $3,075,583 48,672
2020-06-30 $3,989,800 51,856
2020-03-31 $4,342,658 58,088